Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Lipton

Showing results (1-10 of 935) with videos related to

Pageof 94
Sort By:
Evidence-Based Medicine|January 22, 2011
Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment onlyRichard B Lipton
Neurology. Clinical Practice|July 26, 2019
Spotlight on headacheRichard B Lipton
Neurology|February 4, 2009
Tracing transformation: chronic migraine classification, progression, and epidemiologyRichard B Lipton
Continuum (Minneapolis, Minn.)|August 8, 2015
Risk Factors for and Management of Medication-Overuse HeadacheRichard B Lipton
Neurology|July 31, 2013
Comment: Cranial autonomic symptoms typify migraine in children and adolescentsRichard B Lipton
Nature Clinical Practice. Neurology|August 26, 2006
How useful is the HIT-6 for measuring headache-related disability?Richard B Lipton
Continuum (Minneapolis, Minn.)|April 3, 2024
Preventive Treatment of MigraineRichard B Lipton
Nature Reviews. Neurology|February 8, 2011
Headache in 2010: Progress in headache mechanisms and managementRichard B Lipton
Neurology|February 25, 2009
Conventional management and novel modalities for improved treatment of chronic migraineRichard B Lipton
Headache|June 6, 2003
Editorial commentRichard B Lipton
Pageof 94

Showing results (1-10 of 935) with videos related to

Sort By:
Pageof 94
Evidence-Based Medicine|January 22, 2011
Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment onlyRichard B Lipton
Neurology. Clinical Practice|July 26, 2019
Spotlight on headacheRichard B Lipton
Neurology|February 4, 2009
Tracing transformation: chronic migraine classification, progression, and epidemiologyRichard B Lipton
Continuum (Minneapolis, Minn.)|August 8, 2015
Risk Factors for and Management of Medication-Overuse HeadacheRichard B Lipton
Neurology|July 31, 2013
Comment: Cranial autonomic symptoms typify migraine in children and adolescentsRichard B Lipton
Nature Clinical Practice. Neurology|August 26, 2006
How useful is the HIT-6 for measuring headache-related disability?Richard B Lipton
Continuum (Minneapolis, Minn.)|April 3, 2024
Preventive Treatment of MigraineRichard B Lipton
Nature Reviews. Neurology|February 8, 2011
Headache in 2010: Progress in headache mechanisms and managementRichard B Lipton
Neurology|February 25, 2009
Conventional management and novel modalities for improved treatment of chronic migraineRichard B Lipton
Headache|June 6, 2003
Editorial commentRichard B Lipton
Pageof 94